Weinhandl, Eric D.

US Renal Data System 2020 annual data report: epidemiology of kidney disease in the United States

Johansen, K. L., Chertow, G. M., Foley, R. N., Gilbertson, D. T., Herzog, C. A., Ishani, A., Israni, A. K., Ku, E., Kurella Tamura, M., Li, S., et al. (2021) · American Journal of Kidney Diseases

Chronic Kidney Disease and DiabetesDialysis and Renal Disease Management

Cited by 724

Excerpts from the US Renal Data System 2009 Annual Data Report

Collins, A. J., Foley, R. N., Herzog, C., Chavers, B. M., Gilbertson, D., Ishani, A., Kasiske, B. L., Liu, J., Mau, L.-W., McBean, M., et al. (2010) · American Journal of Kidney Diseases

Chronic Kidney Disease and DiabetesDialysis and Renal Disease Management

Cited by 436

US Renal Data System 2021 Annual Data Report: Epidemiology of Kidney Disease in the United States

Johansen, K. L., Chertow, G. M., Gilbertson, D. T., Herzog, C. A., Ishani, A., Israni, A. K., Ku, E., Li, S., Li, S., Liu, J., et al. (2022) · American Journal of Kidney Diseases

Chronic Kidney Disease and DiabetesDialysis and Renal Disease Management

Cited by 294

Disparities in SGLT2 Inhibitor or Glucagon-Like Peptide 1 Receptor Agonist Initiation Among Medicare-Insured Adults With CKD in the United States

Zhao, J. Z., Weinhandl, E. D., Carlson, A. M., & St. Peter, W. L. (2023) · Kidney Medicine

Diabetes Treatment and ManagementChronic Kidney Disease and Diabetes

Cited by 33

Associations of Community Water Lead Concentrations with Hemoglobin Concentrations and Erythropoietin-Stimulating Agent Use among Patients with Advanced CKD

Danziger, J., Mukamal, K. J., & Weinhandl, E. (2021) · Journal of the American Society of Nephrology

Heavy Metal Exposure and ToxicityErythropoietin and Anemia Treatment

Cited by 26

Hypoglycemia Risk With SGLT2 Inhibitors or Glucagon-Like Peptide 1 Receptor Agonists Versus Sulfonylureas Among Medicare Insured Adults With CKD in the United States

Zhao, J. Z., Weinhandl, E. D., Carlson, A. M., & St. Peter, W. L. (2022) · Kidney Medicine

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 26

Longitudinal course of pharmacotherapy in obsessive–compulsive disorder

Grant, J. E., Mancebo, M. C., Weinhandl, E., Odlaug, B. L., Eisen, J. L., & Rasmussen, S. A. (2013) · International Clinical Psychopharmacology

Obsessive-Compulsive Spectrum DisordersAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 12

Glucose-Lowering Medication Use in CKD: Analysis of US Medicare Beneficiaries Between 2007 and 2016

Zhao, J. Z., Weinhandl, E. D., Carlson, A. M., & St. Peter, W. L. (2021) · Kidney Medicine

Diabetes Treatment and ManagementChronic Kidney Disease and Diabetes

Cited by 9